AC Immune SA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AC Immune SA generated cash of -$60,408,000, which is more than the previous year. Cash used in financing activities reached the amount of $43,250,000 last year. Net change in cash is therefore $46,908,000.
Cash Flow
| 2014 | -17.62M | -131K | 9.80M |
|---|---|---|---|
| 2015 | 44.08M | -244K | 27.77M |
| 2016 | -5.64M | -899K | 78.79M |
| 2017 | -22.09M | -1.84M | 271K |
| 2018 | -44.07M | -32.03M | 109.37M |
| 2019 | 55.22M | -66.88M | 49.61M |
| 2020 | -59.51M | 28.32M | -803K |
| 2021 | -65.68M | -53.66M | 40.74M |
| 2022 | -73.56M | 23.76M | -1.34M |
| 2023 | -60.40M | 65.64M | 43.25M |
ACIU Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 31.58M | 82.21M | 160.89M | 193.58M | 156.46M | 124.37M | 152.21M | 76.52M | 3.30M | 11.25M |
Operating activities | ||||||||||
Net income | -54.23M | -70.75M | -72.99M | -61.92M | 45.44M | -50.95M | -26.41M | -7.09M | 20.27M | 10.74M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.21M | 2.35M | 2.40M | 1.96M | 1.69M | 961K | 580K | 278K | 287K | 298K |
Stock-based compensation expense | 4.36M | 3.33M | 4.12M | 4.08M | 2.83M | 0 | 1.57M | 1.31M | 540K | 210K |
| Deferred income tax benefit | 4.36M | 3.33M | 4.12M | 4.08M | 2.83M | 0 | 1.57M | 1.31M | 540K | 210K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -14.8M | 36K | -99K | -25K | -68K | 698K | -401K | -248K | 25.66M | -25.74M |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | -2.85M | 2.59M | -141K | 341K |
Cash generated by operating activities | -60.40M | -73.56M | -65.68M | -59.51M | 55.22M | -44.07M | -22.09M | -5.64M | 44.08M | -17.62M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -65M | -30M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -801K | -1.23M | -2.63M | -1.70M | -1.88M | -1.85M | -1.80M | -899K | -244K | -128K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 65.64M | 23.76M | -53.66M | 28.32M | -66.88M | -32.03M | -1.84M | -899K | -244K | -131K |
Financing activities | ||||||||||
Common Stock Issued | 43.79M | 0 | 16.72M | 100K | 0 | 111.53M | 0 | 69.38M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -100K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -548K | -569K | -513K | -432K | 50.05M | -339K | 200K | 0 | 55K | 0 |
Cash used in financing activities | 43.25M | -1.34M | 40.74M | -803K | 49.61M | 109.37M | 271K | 78.79M | 27.77M | 9.80M |
Net Change In Cash | 46.90M | -50.63M | -78.67M | -32.69M | 37.12M | 32.08M | -27.83M | 75.68M | 73.21M | -7.94M |
Cash at end of period | 78.49M | 31.58M | 82.21M | 160.89M | 193.58M | 156.46M | 124.37M | 152.21M | 76.52M | 3.30M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |